Russellville Health Care Inc | |
705 Northeast Gandy Street, Russellville, Alabama 35653 | |
(256) 332-3773 | |
Name | Russellville Health Care Inc |
---|---|
Location | 705 Northeast Gandy Street, Russellville, Alabama |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 50 |
Occupancy Rate | 76.2% |
Medicare ID (CCN) | 015071 |
Legal Business Name | Russellville Health Care, Inc. |
Ownership Type | For Profit - Corporation |
NPI Number | 1124749163 |
Organization Name | ARABELLA HEALTH AND WELLNESS OF RUSSELLVILLE LLC |
Doing Business As | EAST VILLAGE NURSING AND REHAB PROPCO LLC |
Address | 705 Gandy St Ne, Russellville, AL 35653 |
Phone Number | 256-332-3773 |
News Archive
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society.
The Lancet Oncology published this week findings from a study, which showed that the new oral therapy IMNOVID®▼ (pomalidomide), used in combination with low-dose dexamethasone demonstrated a significant survival advantage over high-dose dexamethasone alone, in patients with relapsed and refractory multiple myeloma (rrMM).1
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.
Feeling stressed out increases the likelihood that elderly people will develop mild cognitive impairment—often a prelude to full-blown Alzheimer's disease. In a new study, scientists at Albert Einstein College of Medicine and Montefiore Health System found that highly stressed participants were more than twice as likely to become impaired than those who were not.
› Verified 3 days ago
NPI Number | 1326120502 |
Organization Name | RUSSELLVILLE HEALTH CARE, LLC |
Doing Business As | RUSSELLVILLE HEALTH CARE, INC. |
Address | 705 Gandy St Ne, Russellville, AL 35653 |
Phone Number | 256-332-3773 |
News Archive
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society.
The Lancet Oncology published this week findings from a study, which showed that the new oral therapy IMNOVID®▼ (pomalidomide), used in combination with low-dose dexamethasone demonstrated a significant survival advantage over high-dose dexamethasone alone, in patients with relapsed and refractory multiple myeloma (rrMM).1
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.
Feeling stressed out increases the likelihood that elderly people will develop mild cognitive impairment—often a prelude to full-blown Alzheimer's disease. In a new study, scientists at Albert Einstein College of Medicine and Montefiore Health System found that highly stressed participants were more than twice as likely to become impaired than those who were not.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society.
The Lancet Oncology published this week findings from a study, which showed that the new oral therapy IMNOVID®▼ (pomalidomide), used in combination with low-dose dexamethasone demonstrated a significant survival advantage over high-dose dexamethasone alone, in patients with relapsed and refractory multiple myeloma (rrMM).1
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.
Feeling stressed out increases the likelihood that elderly people will develop mild cognitive impairment—often a prelude to full-blown Alzheimer's disease. In a new study, scientists at Albert Einstein College of Medicine and Montefiore Health System found that highly stressed participants were more than twice as likely to become impaired than those who were not.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 20.37 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.33 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 50.88 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.62 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 7.45 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.66 | 5.05 |
Percentage of long-stay residents who were physically restrained | 6.17 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 3.7 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.38 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 28.66 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 64 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 26.83 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 29.14 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 2.22 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 77.42 | 82.93 |
News Archive
Anavex Life Sciences Corp. will present the most recent data showing the therapeutic potential of ANAVEX compounds in animal models of Alzheimer's disease at a special symposium of the 34th annual meeting of the Japan Neuroscience Society.
The Lancet Oncology published this week findings from a study, which showed that the new oral therapy IMNOVID®▼ (pomalidomide), used in combination with low-dose dexamethasone demonstrated a significant survival advantage over high-dose dexamethasone alone, in patients with relapsed and refractory multiple myeloma (rrMM).1
Patients with Parkinson's disease (PD) and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of PD and its symptomatic treatment.
Feeling stressed out increases the likelihood that elderly people will develop mild cognitive impairment—often a prelude to full-blown Alzheimer's disease. In a new study, scientists at Albert Einstein College of Medicine and Montefiore Health System found that highly stressed participants were more than twice as likely to become impaired than those who were not.
› Verified 3 days ago
Burns Nursing Home, Inc. Location: 701 Monroe Street Nw, Russellville, Alabama 35653 Phone: (256) 332-4110 | |
Terrace Manor Nursing & Rehabilitation Center, Inc Location: 390 Underwood Road, Russellville, Alabama 35653 Phone: (256) 332-3826 | |
Russellville Health Care Inc Location: 705 Northeast Gandy Street, Russellville, Alabama 35653 Phone: (256) 332-3773 |